Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tecovirimat (monohydrate)

Tecovirimat (ST-246) monohydrate is the monohydrate form of Tecovirimat. Tecovirimat monohydrate is an orally bioavailable and selective compound against orthopoxviruses [including vaccinia, monkeypox, camelpox, cowpox, ectromelia (mousepox), smallpox and variola viruses]. Tecovirimat monohydrate is evaluated against vaccinia, cowpox virus, ectromelia virus with EC50 values of 0.01 μM, 0.48 μM and 0.05 μM, respectively. Tecovirimat monohydrate targets the orthopoxvirus protein VP37 which is necessary for membrane envelopment of intracellular mature virus particles to form enveloped virus. Tecovirimat monohydrate exerts antiviral activity on the target of the cowpox virus V061 gene, which is homologous to vaccinia virus F13L, encoding a major envelope protein (p37) required for production of extracellular virus. Tecovirimat monohydrate could be used in the study for orthopoxvirus-induced diseases[1][2][3][4][5].

Product Specifications

CAS Number

1162664-19-8

Product Name Alternative

ST-246 (monohydrate)

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Arenavirus; Orthopoxvirus

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/tecovirimat-monohydrate.html

Purity

99.97

Smiles

O=C(NN(C([C@]1([H])[C@@]2([H])[C@@](C3)([H])[C@@]3([H])[C@@](C=C2)([H])[C@]41[H])=O)C4=O)C5=CC=C(C(F)(F)F)C=C5.O

Molecular Formula

C19H17F3N2O4

Molecular Weight

394.34

Precautions

H302, H315, H319, H335

References & Citations

[1]TYAVANAGIMATT SR, et al., Rehydration of micronized tecovirimat monohydrate. WO2015077143.|[2]Yang G, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge[J]. J Virol. 2005 Oct;79 (20) :13139-49. |[3]Quenelle DC, et al. Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice[J]. Antimicrob Agents Chemother. 2007 Feb;51 (2) :689-95. |[4]Russo AT, et al. An overview of Tecovirimat monohydrate for smallpox treatment and expanded anti-orthopoxvirus applications[J]. Expert Rev Anti Infect Ther. 2021 Mar;19 (3) :331-344. |[5]DeLaurentis CE, et al. New Perspectives on Antimicrobial Agents: Tecovirimat monohydrate for Treatment of Human Monkeypox Virus[J]. Antimicrob Agents Chemother. 2022 Dec 20;66 (12) :e0122622. |[6]Almehmadi M, et al. A Glance at the Development and Patent Literature of Tecovirimat monohydrate: The First-in-Class Therapy for Emerging Monkeypox Outbreak[J]. Viruses. 2022 Aug 25;14 (9) :1870.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Launched

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Uncoated Human sST2 (Soluble ST2) ELISA Kit
E-UNEL-H0113-01 5x 96 Tests

Uncoated Human sST2 (Soluble ST2) ELISA Kit

Sign In for Pricing
View Details
Uncoated Human sST2 (Soluble ST2) ELISA Kit
E-UNEL-H0113-02 15x 96 Tests

Uncoated Human sST2 (Soluble ST2) ELISA Kit

Sign In for Pricing
View Details
Frozen Tissue Sections, Endometrium
CS626960 5x 5 µm

Frozen Tissue Sections, Endometrium

Sign In for Pricing
View Details
Spectrin beta III (SPTBN2) (SPTBN2/1778), 0.2mg/mL
BNUB1778-500 1x 500 µL

Spectrin beta III (SPTBN2) (SPTBN2/1778), 0.2mg/mL

Sign In for Pricing
View Details
Recombinant Caspase 8 Monoclonal Antibody
E-AB-81540-01 50 µL

Recombinant Caspase 8 Monoclonal Antibody

Sign In for Pricing
View Details
Recombinant Caspase 8 Monoclonal Antibody
E-AB-81540-02 100 µL

Recombinant Caspase 8 Monoclonal Antibody

Sign In for Pricing
View Details